Abstract
Beta-Sitosterol (SIT) is an active TCM compound employed to treat diabetic retinopathy (DR). A network pharmacology approach to understanding the active ingredients and the therapeutic mechanisms underlying DR has not been pursued.
The potential targets for DM were identified according to the MedGene, Gendome, HGNC, OMIM, GeneCards, PheGenI, GEO, and STRING database. The herb and components were predicted and screened by network pharmacology through oral bioavailability and drug-likeness filtration using the Traditional Chinese Medicine Systems Pharmacology Analysis Platform database. A network pharmacology prediction and network analysis were
We found the Top 15 DR-related genes by screening in 9 databases. 26 kinds of TCM and nearly 300 kinds of active ingredients. SIT exists in 10 kinds of DR-treat TCM. The comprehensive network pharmacology approach was successful in identifying 23 kinds of core genes for SIT treating DR. ERBB3 and IGF2-related PI3K-Akt signaling pathway or EDN3, IGF2 and SPP1-related receptor ligand activity pathway might be the main pharmacological targets, and pathways in DR. We speculated that SIT was effective for the treatment of DR.
Based on the network pharmacology, we predicted the potential targets of SIT in treating DR and helped to illustrate the mechanism of action. Our study identifies
Author Contributions
Copyright© 2024
Sun Kexin, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests None of the authors have any financial/conflicting interests to disclose. The authors declare that they have no conflicts of interest to report regarding the present study.
Funding Interests:
Citation:
Introduction
Diabetes mellitus (DM) is a metabolic disorder caused by environmental and genetic factors. The long-time hyperglycemic status would cause serious damage to the eye, kidneys, blood vessels, nerves, and heart1. Because its prevalence and related disability and mortality are quite high, DM has become a critical health problem globally. The economic cost based on The International Diabetes Federation (IDF) showed that treating diabetes each year cost more than 15% of total health expenditure annual expenditures globally2-5. DM shows a considerable impact on costs to society, and health systems and directly affects the quality of people's lives. Diabetic retinopathy (DR) is the first and most common microvascular complication of DM. According to the Network pharmacology (NP) first appeared in 2007 with a publishment of Pro. Hopkins from the University of Dundee, UK. It is a new discipline based on the theory of systems biology. It is proposed as a promising approach to discovering TCM and herbs from a systems perspective and at the molecular level9. By using NP, Dan He’s group illuminated the potential targets of LiuWei DiHuang Wan to treat DM9. Xiao-Yan Cui’s group reported the combined effects of two herbs Sanqi and Huangjing used together and their pharmacological mechanism10. Haoran Li explored the Compound-Xueshuantong Capsule in DR treatment11. These articles suggested that NP can be used to explore the chemical compositions of traditional Chinese herbs and their therapeutic mechanisms underlying DR. Therefore, our study used NP, collected data and information from multiple data platforms, explored a new effective drug in DR treatment, and revealed its active components, potential targets, and signal pathways. Beta-Sitosterol was obtained by screening. Our research is the first to identify a potential bioactive compound and elucidate its mechanisms in DR treatment using the NP approach. The IDF estimates 10% of adults might be diagnosed with DM in 2040. There will be 629 million people with diabetes worldwide in 2045. At that time, the death rate of DM will be greater than the death rate combined with AIDS, tuberculosis, and malaria. According to the research data of “ With the development of the economy and society and the increasingly aging society of population, the global prevalence of DM and the prevalence of diabetes-related complications are continually increasing ( Intravitreal Injection of anti-VEGF (intravitreal vascular endothelial growth factor inhibitors) or steroid hormone is a simple but highly effective treatment in DR, but up to 50% of patients failed to respond. And repeated injection leads to many complications like cataracts or vitreous opacity. The patients of DM had great individual differences in the course and severity of DR. Some patients with long-term diabetes do not develop diabetic retinopathy despite poor glycemic control, at the same time, others develop diabetic retinopathy rapidly. Some researchers believe Traditional Chinese medicine (TCM) is a system based on the holistic view, which is composed of Yin and Yang and the five basic elements. And these concepts and thinking are used to explain the human body structure, the physiological functions, pathological changes, diagnosis, and treatment in multi factors, different levels, which focus on the five internal organs. Therefore, based on the mechanism research and treatment of DR, it is a helpful way to find out a useful drug by the biological network of TCM.
Materials And Methods
The bibliometric analysis developed in this research was based on the online database of the Web of Science (https://www.webofscience.com/wos/alldb/basic-search). These search expressions included applying the terms diabetic retinopathy OR DR , which seeks words on titles, and abstracts, from 2002 to 2022. A total of 27564 publications were retrieved after refinement. All analyses were performed using the "Analyzing Results" tool provided by WoS with MS Excel support (v. 2016) to perform calculations and to develop graphs (visualization of bibliometric indicators) using the following information: i) several publications, ii) several citations iii) impact factor (for journals) and iv) h-index (for journals and authors). The DR-related targets were screened 3 types from 9 databases sources: (1) Database based: ①MedGene (https://www.ncbi.nlm.nih.gov/), ②Gendome (https://ai.citexs.com/), ③HGNC (https://www.genenames.org/), ④OMIM (http://www.omim.org/), ⑤GeneCards (https://www.genecards.org/), ⑥PheGenI (https://www.ncbi.nlm.nih.gov/gap/phegeni) These searches expressions consisted in applying the terms diabetic retinopathy OR DR , only Homo sapiens proteins linked to DR were selected. We got 4400 individual genes total, and details are described in Supply 1. We next use the R package UpSetR to visualise (2) GEO Chip based: Using the NCBI Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/), the GSE41019, GSE60436, and GSE146615 related chips were obtained using diabetic retinopathy OR DR as the search term in Homo sapiens. The chips correspond to eye tissues and cell lines. The 3 sets of chips included DNA and RNA experiments, and their annotation files are the platform GPL6884 and GLP10558. We combined the same platform information to analyze. (3) STRING Connected based: Cytoscape (Version 3.9.1) is an open-source software used to analyze and visualize biological networks. We installed the String and String Enrichment Apps, search tools for Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP, https://tcmspw.com/tcmsp.php) is a database based on the framework of systems pharmacology for herbal medicine. The CloudPhar traditional Chinese medicine (TCM-LTM, https://cloud.tasly.com/#/tcm/home) is used as the discovery of the complex mechanism of action of TCM, which contains 48126 prescriptions, 9122 plants, 34967 active ingredients, and 13109 targets for user querying the symptom, prescription, herb, and ingredient of TCM. The keyword diabetic retinopathy or diabetes + retina was searched in both 2 databases. Wayne diagram (http://jvenn.toulouse.inra.fr/app/example.html) was used to display the intersection of DR putative TCM. 26 herbs were obtained. Next, all these herbs were retrieved in TCMSP and screened with OB≧ 30% and LD≧ 0.18. The chemical compounds of each herb were obtained. Sorting by occurrence times, we got TOP. 10. Beta-Sitosterol is the most vital compound in TCM of TCM, which is contained in 12 of 26 kinds of DR-treatment herbs. TCMSP website was used to predict potential targets of Beta-Sitosterol for treating DR. The UniProt database (https://www.uniprot.org/) was used to convert the target name into the official name. Next step, we matched Beta-Sitosterol treatment targets with DR targets to obtain overlapping targets. The core targets of Beta-Sitosterol in DR treatment were imported into the Meta-scape platform, and analyze parameters of P value < 0.01, a minimum count of 4, and an enrichment factor >1.5 (the enrichment factor is the ratio between the observed counts and the counts expected by chance) were set. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and GSEA pathway enrichment analyses on core targets were performed. We constructed two networks: (1) A compound-target network; and (2) A target-pathway network. Protein-protein interaction (PPI) data were attained by STRING.
Results
Only “Homo sapiens” targets linked to DR were selected in 6 different databases mentioned above. We got 4400 genes total, and details are described in Supplement 1. Each target got a score by the number of appearance times ( We next merge GSE41019 and GSE60436 which are from the same platform. Using R package ggplot2 to visualise these chips (
In total, 360 and 45 kinds of herbs were obtained from the TCMSP and TCM-LTM. Paeoniae Radix Alba, licorice, and other 26 herbs were included in both 2 databases ( Beta-sitosterol (SIT) is a kind of sterol occurred SIT has 2612 potential targets after removing duplicates. Based on the intersection of drug and disease targets, we obtained 23 genes ( All DR-related genes were imported into Cytoscape. A cluster network (MCL) in String App was used to build new network clustering ( Aside from MedGene and HGNC database, other information got simplified. Cluster Gendome includes PI3K, GRB2, CRK, FLT4, VEGF, EGF, NOX1, PGF, CTGF, and PDGF. Cluster GeneCards includes COX4, STAT3, MYC, SOCS3, PEX, LSM2, POLR, SRA1, B2M, BRCA1, WWOX, USP5 and more than 500 points. Cluster PheGenI includes FLT4, CTNNB1, SRC, APOA1, RAC1, ROCK2, NTRK2, CLU, CCNA2, IL-1B, TNF, IN27. Cluster OMIM includes PRKCD, MMP14, VEGFA, PTPN6, MMP2, IGF1, KDR, TAC1, VIP. Cluster Pubmed based on String Pubmed query includes VEGFA, PGF, IL-1B, TNF, INS, IL-6, AKR1B1, and ALB. Cluster String based on String disease query includes VEGFA, CTGF, FN1, THBS1, KDR, CDH5, PTPRB, THBS1, and TEK with high degree values. Cluster GEO includes CPEB1, AURKA, CKS2, TTK, CCNB2, CDKN3, HJURP, PI3K ( GSEA analysis was used first to analyze GEO database information, which was enriched to 33 pathways (Supplement 6). The top 5 main pathways included biocarta MAPK pathway, KEGG Alanine Aspartate, and Glutamate metabolism, Reactome export of viral ribonucleoproteins from the nucleus, Reactome Gene silencing by RNA and reaction HCMV early events ( The GO and KEGG pathway enrichment analysis was performed on the total related targets in DR and the above-mentioned 7 modules (Cluster GEO, Cluster GeneDoma, Cluster OMIM, Cluster PheGene, Cluster GeneCard, Cluster Pubmed, and Cluster String). Total DR-related targets enriched to Human cytomegalovirus infection, Apoptosis, NOD-like receptor signaling pathway, and other 12 pathways ( Next, all Clusters were enriched to 11 pathways, respectively, which were enriched respectively and mainly in the PI3K-Akt signaling pathway, positive regulation of leukocyte cell-cell adhesion, and regulation of T cell activation The GO and KEGG pathway enrichment analysis was performed on the SIT ( We first use the 23 genes of both DR-related and SIT-related to enrich, PI3K-Akt signaling pathway (p= 0.035), focal adhesion(p= 3.21E-06), platelet-derived growth factor binding (PDGF, p= 0.007), extracellular matrix binding (p= 0.007) are high enrichment level ( In the DR-SIT network, some signaling pathways (such as the AGE-RAGE signaling pathway in diabetics, PI3K-Akt signaling pathway, and EGFR tyrosine kinase inhibitor resistance) with higher degrees are closely related to the development of DR ( We use bioinformatics analysis to screen the core genes for SIT in treating DR, ERBB3, HLA-DRB1, SPP1, CXCL10, NOX4, LOX, FBLN1, LEP, CAV1, IGF2, CD28, UCHL1, COL4A1, EDN3, BIRC5, PDGFRA, LGALS1, GSN, AURKA, TPX2, SIRPA, RIPK2, ANXA2 in the cross pathway. COL4A1, ERBB3, IGF2, PDGFRA, and SPP1 related PI3K-Akt signaling pathways or EDN3, IGF2, CXCL10, LEP, and SPP1 related receptor ligand activity pathways might be the main pharmacological targets, and pathways in DR (Fig. 5C-5D).
VEGFA
ENSG00000112715
4
GCK
ENSG00000106633
4
INS
ENSG00000254647
4
INSR
ENSG00000171105
4
ACE
ENSG00000159640
4
IGF1
ENSG00000017427
4
PON1
ENSG00000005421
4
EPO
ENSG00000130427
4
CXCL12
ENSG00000107562
4
MMP2
ENSG00000087245
4
SERPINF1
ENSG00000132386
4
ANGPT2
ENSG00000091879
4
KDR
ENSG00000128052
4
NOX4
ENSG00000086991
4
PDGFB
ENSG00000100311
4
Beta-sitosterol
MOL000358
Lycii Cortex, Scutellariae Radix, Panax Ginseng C. A. Mey., Figwort Root, Radix Rhei Et Rhizome, Angelicae Sinensis Radix, Cistanches Herba, Achyranthis Bidentatae Radix, Cornus Officinalis Sieb. Et Zucc., Glehniae Radix, Cyathulae Radix, Paeoniae Radix Alba (12)
Quercetin
MOL000098
Glehniae Radix, Cyathulae Radix, licorice, Coptidis Rhizom, Hedysarum Multijugum Maxim., Cortex Moutan, Achyranthis, Bidentatae Radix, Ginseng Folium, Cistanches Herba, Erigeron Breviscapus (10)
Kaempferol
MOL000422
Hedysarum Multijugum Maxim., Cortex Moutan, Achyranthis, Bidentatae Radix, Ginseng Folium, Erigeron Breviscapus, licorice, Paeoniae Radix Alba, Asari+D:Z Radix Et Rhizoma, Panax Ginseng C. A. Mey., Anemarrhenae Rhizoma (10)
Stigmasterol
MOL000449
Angelicae Sinensis Radix, Rehmanniae Radix Praeparata, Lycii Cortex, Scutellariae Radix, Panax Ginseng C. A. Mey., nemarrhenae Rhizoma, Achyranthis Bidentatae Radix, Rhizoma Dioscoreae, Cornus Officinalis Sieb. Et Zucc., Glehniae Radix (10)
Sitosterol
MOL000359
Alisma Orientale (Sam.) Juz., Scutellariae Radix, Rehmanniae Radix, Praeparata, Figwort Root, Ginseng Folium, Cortex Moutan, licorice, Cornus Officinalis Sieb. Et Zucc., Paeoniae Radix Alba (9)
EIC
MOL000131
Cinnanmomi Cortex, Scutellariae Radix, Rehmanniae Radix Praeparata, Hedysarum Multijugum Maxim., Cornus Officinalis Sieb. Et Zucc., Glehniae Radix, Radix Salviae (7)
DBP
MOL000676
Scutellariae Radix, Panax Ginseng C. A. Mey., Achyranthis Bidentatae Radix, Licorice, Cornus Officinalis Sieb. Et Zucc., Paeoniae Radix Alba (6)
DIBP
MOL000057
Cinnanmomi Cortex, Achyranthis Bidentatae Radix, licorice, Cornus Officinalis Sieb. Et Zucc., Atractylodes Macrocephala Koidz. (5)
Oleic acid
MOL000675
Radix Salviae, Cortex Moutan, Figwort Root, Lycii Cortex, Cinnanmomi Cortex (5)
Mairin
MOL000211
Paeoniae Radix Alba, licorice, Hedysarum Multijugum Maxim., Cortex Moutan (4)
Discussion
In the past decades, DM has imposed substantial economic and social burdens globally. DM patients are at increased risk for microvascular complications, especially retinopathy and nephropathy. (YOU CAN ADD REFERENCE OR NOT, THIS PART LOOKS MORE INTRODUCTION. TOU CAN MENTION MILLION PEOPLE WORLWIDE) The Chinese developed TCM, a prescription of their traditional medicines, based on their own experiences of its usage, and eastern ideas. TCM nowadays has been used as a resource for developing antitumor, anti-oxidation, anti-proliferation, and anti-inflammation drugs12. It has been demonstrated by landmark studies that are using TCM oral, which was a homology of medicine and food as the main raw materials, reduces the risk of development and progression of DR9,13,14. Although traditional Chinese herbs were widely used for DM, hypertension and other chronic illness for two millennia in China, their mechanisms are unclear yet. In this work, network analysis and bioinformatics were employed to screen the core action targets of the DR treatment. This paper uses the research ideas of network pharmacology to explore the potential drug and predict the possible targets and pathways in the SIT treatment of DR. By searching for computer retrieval, we respectively evaluated the disease-related Databases, the TCM Databases, and the Web of Science. We first found out 26 kinds of TCM like Ginkgo Semen, Mori Fructus, Zanthoxyli Pericarpium, Portulacae Herba, and Coriandri Sativi Herba are also used as edible spice plants in the Asian diet can be used to treat DR. To explore the precise mechanisms of TCM treatment DR, we next investigated the vital active phytochemicals and molecular mechanisms of these TCM. The big data of 9 databases sources predicted that VEGF, CTGF, KDR, PGF, ANGPT, PON1, FLT, STAT3, MMP2, TEK, FN1, FIGF are highly related to DR. PI3K-Akt signaling pathway is the highest biocarta pathway. Regulation of cell-cell adhesion, response to oxidative stress, and regulation of apoptotic, and epithelial cell proliferation play vital roles in the process of oxidative stress damage and neovascularization in the DR pathological process. SIT is a kind of bioactive phytosterol in plant cell membranes, which has a similar chemical structure to mammalian cholesterol. European Foods Safety Authority (EFSA) suggested that 1.5-2.4 g/day of SIT reduces cholesterol levels in the blood, reducing the risk of heart disease15,16. Sutherland WH et al. reported that plasma plant sterol concentrations were significantly lower in human diabetics compared to normal controls and serum insulin levels were inversely correlated with plasma plant sterol concentration in diabetics17. Jen-Wai Chai et al. reported SIT reduced glucose uptake and adipogenesis in rat adipocytes, which means SIT can be used in DM and weight management18. The data analysis in this paper found that, in the pathogenesis of DR, multiple targets, such as RAGE, MAPK, EGR, SOD1, TGFB1, NOD1, NLRP3, JUN, and MMP2 acted together with VEGF. Inflammatory and glycosylase activity are directly interlinked with the pharmacological action of SIT and in SIT treatment DR. The AGE-RAGE signaling pathway plays a key role in the production of DM vascular complications, especially in DR. In the cellular response to TNF-β stimulus, PDGF binding plays a central role in the process of inflammation and SIT treatment DR. COL4A1, ERBB3, IGF2, PDGFRA, and SPP1 related PI3K-Akt signaling pathway or EDN3, IGF2, CXCL10, LEP, and SPP1 related receptor ligand activity pathway might be the mainly pharmacological targets and pathways in DR.
Conclusion
We use the network pharmacology methods to explore the active ingredients and the potential mechanisms of SIT, a kind of active compound of TCM, underlying their effects on DR. We screened all DR targets from 9 databases and found related to DR by using bioinformatics analysis. Among them, VEGFA, GCK, INS, INSR, ACE, IGF1, PON1, EPO, CXCL12, MMP2, SERPINF1, ANGPT2, KDR, NOX4, PDGFB were selected as high relative genes of DR. Furthermore, ERBB3, HLA-DRB1, SPP1, CXCL10, NOX4, LOX, FBLN1, LEP, CAV1, IGF2, CD28, UCHL1, COL4A1, EDN3, BIRC5, PDGFRA, LGALS1, GSN, AURKA, TPX2, SIRPA, RIPK2, ANXA2 are the core genes for SIT in treating DR. ERBB3 and IGF2 related PI3K-Akt signaling pathway or EDN3, IGF2 and SPP1 related receptor ligand activity pathway might be the mainly pharmacological targets and pathways for SIT in treating DR. We speculated that SIT was effective for the treatment of DR; however, experiments must be performed to verify these results.